First TIL Results: Four Patients, All Responded, One Complete; Panel Pens Reauthorization Drive
In Brief: Lepovetsky Heads New NCI Office Of Technology Development; Temporary Now, Maybe Permanent
FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX
ACS Modifies Pap Test Guidelines
Cancer Letter, PR Firm Settle Out Of Court On Copyright Violation
Comments Invited On Centers Program
Radiation Exposure Mostly Natural, NCRP Report Says
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- No need for a speculum? A new era of HPV screening
- At AACR, Letai announces prevention and screening project for southern Appalachia, describes a future without paylines
There’s “clear evidence that funding is moving and the system is working.” - Forty years after Chernobyl: Little evidence to show that radiation released from the accident increased cancers globally









